{"name":"Ascelia Pharma AB","slug":"ascelia-pharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Mangoral","genericName":"Mangoral","slug":"mangoral","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Mangoral","genericName":"Mangoral","slug":"mangoral","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQRFE3RGxTOWg3eUNSbHdDX2RkR0FkYWtxbmJPWmVfM0tSZm5zbDZZdU9PTEJodXNYa2lZV2JyUnhzUFdhdmU4V190UXZORUxXZWpTZTVIeXRMemxwUEFob2tmazRqWFVRNHNtR1g1cWJOTEtYeWhoRVBvSWozUkRPREE0NFVDTVNObDdPT253MnhBbkxFb3JublFNdExJZ0xsb2Z6WldFb0FTMVRiMHVXcTRiMDg3bmxrdnpTbkFfWG5XSWc?oc=5","date":"2026-03-30","type":"pipeline","source":"TipRanks","summary":"Ascelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan - TipRanks","headline":"Ascelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNMjBNX2VHOXJaenNNenJ0WnZsYnZXYzJ3VWk4XzJ5aklyQTVBNHZmZjlxVG1COHdhLUhWbDFUckpDZ0tKOWk1bnIyS1A0S3VuNENoQlNSbmQ4ZUt2WTVNZFpuenFmU1B5SnQzNVRKUVhJZWhYMGRTNmU0c1BkdlhSajV6WGRhcUxTLXdhTXhqZkF5aWpMQzFaRmt6SkRZSlZ2R2lxN0dSMHNQNjJGVFAyNFYyMnFDWVJJSnpNRDJnNzdVak8tRDZDMHdXeHdDbWZwSS1TY3V6dGg3azlnUWxleUdWZlEzbEdf?oc=5","date":"2026-03-27","type":"trial","source":"marketscreener.com","summary":"ASCELIA PHARMA ANNOUNCES ACCEPTANCE OF ORVIGLANCE DATA FOR ORAL PRESENTATION AT THE ANNUAL RADIOLOGY CONGRESS ESGAR 2026 - marketscreener.com","headline":"ASCELIA PHARMA ANNOUNCES ACCEPTANCE OF ORVIGLANCE DATA FOR ORAL PRESENTATION AT THE ANNUAL RADIOLOGY CONGRESS ESGAR 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQOHVpbmFVal9TN3hCcTc2aVRDNTZEYV9KMnBsVmd2NHNTZEdoTGhqR1pyb1Z6YTBrcW1XTU82T2RJUVE2TE00T2lnRXk5LVd3SDNoRjhrbDNoME9Od0l3VGZPRUxFYjZSX0JmaHhmUi0zRzhld241ZHliZmk4NWhjSmszQXdaY3pQQ254a2U0UUtVSWJyQS1LZnQ4S25Jd2cxQjlQTlFiQkpndENhN0lndjQ0THRBeWwxUVc1alNWZmJqc1p2WHByMjl0dWY?oc=5","date":"2026-03-27","type":"pipeline","source":"TipRanks","summary":"Ascelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation - TipRanks","headline":"Ascelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQRms5Z05SNnhtYloyeWNpTUE4ZGRCZGI4Nnpjc1RKNU1pcUNiWHBpRWJxY0NoZWY3ZHhCVmZpdUlfbmRwM1JsWXhnM242OVpyT2ptM3JzUkdVREx1d1pweHNVSmVTcEFLTVJQbVlES1VLVlBsU21uOHB3SEVIM2EyelZwMDVXREg3MEpVZFNwQlNHaE1vcXNtWWphYWxQN3BXMV82eXZTTk91Vy1DWDNlU19lcXNoam9NVkpfZXo0dHBqaUN6ajNlX1FYMGk?oc=5","date":"2026-02-04","type":"regulatory","source":"TradingView","summary":"Full Year and Q4 Report 2025: FDA Accepts Orviglance NDA for Review - TradingView","headline":"Full Year and Q4 Report 2025: FDA Accepts Orviglance NDA for Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxORjM1Mmo4WVVWQ05aRTh4VjJvaWxhWmdyWWV0M2ZWc1V4dFhHN2VVaHVoMnRwSjBzajdtTExlNTYydDgyTHdTdUM4MFl4di05V0YxOVhrZlZOcFdrZzFDbmhCNDJDMGp3V3NyX3lpd3NzdHJGQTNnZW4tck5pUThpSXNn?oc=5","date":"2026-01-27","type":"pipeline","source":"The Pharma Letter","summary":"Gedea Biotech appoints new CEO - The Pharma Letter","headline":"Gedea Biotech appoints new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQTFNoRHlaTkVTZElvU1FrY3U0eW8tYzFEZVoxc0FWQ1JWNUZhZWJqRWVsR3NUNnBGT09ndS1XeV9BaDhuczAtYW05UVhQeDE5V1BkdXJyQTk0WGhkOExnRlI0Wi1odzdNaXBFLVctWHl4Qms0aWZpb2lxMEVFQTBybGh2Qk0ydlRqNHNaX0JObjlQXzhRdnJVT0NsNnd0Sk9TbG5ZUXo5N0UyZUcwMHhFanFMMjZrQWJNazhIVHBCQjIxMGNDNmJMUmxzR05zRklKR0dRVTh5djVfcjVxTFI0SjhhRWI4c2lxMl9TWGh3SldINmtpWkhJ?oc=5","date":"2024-05-10","type":"trial","source":"Technology Networks","summary":"Ascelia Pharma Successfully Meets Primary Endpoint With Strong Headline Results in Orviglance Phase 3 Study - Technology Networks","headline":"Ascelia Pharma Successfully Meets Primary Endpoint With Strong Headline Results in Orviglance Phase 3 Study","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNaFJnRG1TU0pWbjF5YWZackN0SzZ1b00wRDBkOWxDNFQ3WTdaOThhdXZibDFqWlk4Z0w2WEZGdmNiUkVBWEllZkVwQ3E1b0IyaFFnT2NGeXRibWpGR2o3SjQxOXBQd1BHVFAzTDBUT0NWaG5pb3IyNUNtLV9tQXVlYUhqUmZvalpvQWZLR3Z5SmtEa1BkOVlYaDdLamZieTRLeWNpdF9yZWx1SW1GWnAtYmd5LVlyc0dMOWFJa3NLeURiajg?oc=5","date":"2024-05-08","type":"trial","source":"Imaging Technology News","summary":"Ascelia Pharma Meets Primary Endpoint in Phase 3 Study of Orviglance Liver Imaging Contrast Agent Drug Candidate - Imaging Technology News","headline":"Ascelia Pharma Meets Primary Endpoint in Phase 3 Study of Orviglance Liver Imaging Contrast Agent Drug Candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE5pNl8tbWQ3S3VYMU51Yld4SVRjdFZKa1pMZkZkeVRaaXJmcjRoQ3ROaENTVE0wNEZXS05NcHY0RGxlTi1VbC1WM2FzaHFOSTljcWhXUmNOSQ?oc=5","date":"2021-04-06","type":"pipeline","source":"Yahoo Finance UK","summary":"NextCell Pharma AB (NXTCL.ST) stock price, news, quote and history - Yahoo Finance UK","headline":"NextCell Pharma AB (NXTCL.ST) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQaVlyMGZ4LVBvaDFGem1jcTFuRzFYem1QNkVSdGxsNUVmcGdXMnFwcWE3M25hWWROeVU1dk9ObkZTVUxaay1kYUJWNWtHUTk4NTBrdUgtMXBkUl9TQXVudzJKR1M2UFBycURnTEZ4RFhJOFFVQ1p4NkN6b1lYVHdxWVU0amU?oc=5","date":"2015-12-01","type":"pipeline","source":"Imaging Technology News","summary":"RFID Tracks Contrast Delivery in Power Injector - Imaging Technology News","headline":"RFID Tracks Contrast Delivery in Power Injector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVFNwOG5KXzZGSUQ2RnY2RWxFRFliTlM4dExxM2ZicDJXR3dnVDFVNnFYRVAtM0pVZC1YV0s2bERjVGVWODZKVWpRUGEyazN6OVBGT2NiUF80OHpEbzNHYmlpTWFKZmo3THFRZFVEOTFKNFQzYVFnTWhoQXBBdHRDcERvaDNJaW9neGFhZ1BTanhjV2ZlbmlSTlhoLW5DWTFRRlBYQTZVQkVkZw?oc=5","date":"2012-02-29","type":"deal","source":"Imaging Technology News","summary":"Lantheus Announces Partnership for Distribution of Definity Echo Contrast in China - Imaging Technology News","headline":"Lantheus Announces Partnership for Distribution of Definity Echo Contrast in China","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}